Cohance Lifesciences Limited
COHANCE
Peringkat dalam Saham
#6369
Headquartered in Hyderabad, Cohance Lifesciences Limited operates as a... Headquartered in Hyderabad, Cohance Lifesciences Limited operates as a pharmaceutical enterprise, with primary expertise in contract development and manufacturing (CDMO) services. Its business scope also includes the creation of active pharmaceutical ingredients (APIs) and diverse specialty chemicals. The company, previously known as Suven Pharmaceuticals Limited, underwent a corporate rebranding following its amalgamation with Cohance Lifesciences, a transition officially effective May 1, 2025.
Harga Saham
$5.05
Terakhir disinkronkan: 2026-10-19
Kapitalisasi Pasar
$1.93B
Perubahan (1 hari)
-1.44%
Perubahan (1 tahun)
-57.38%
Negara
IN
Perdagangan Cohance Lifesciences Limited (COHANCE)
Kategori
Healthcare
EPS untuk Cohance Lifesciences Limited (COHANCE)
EPS per June 2025 TTM: $0.11
Menurut laporan keuangan terbaru dan harga saham Cohance Lifesciences Limited, EPS perusahaan saat ini (TTM) adalah $0.11. Pada akhir 2024, perusahaan memiliki EPS sebesar $0.14 penurunan dibandingkan dengan EPS tahun 2023 sebesar $0.20.
Riwayat EPS untuk Cohance Lifesciences Limited dari 2019 hingga 2026
EPS di akhir setiap tahun
| Tahun | EPS | Mengubah |
|---|---|---|
| 2026 (TTM) | $0.11 | -9.42% |
| 2025 | $0.12 | -13.07% |
| 2024 | $0.14 | -28.03% |
| 2023 | $0.20 | -16.30% |
| 2022 | $0.23 | 20.83% |
| 2021 | $0.19 | 17.60% |
| 2020 | $0.17 | 167.48% |
| 2019 | $0.06 | 0.00% |
EPS untuk perusahaan sejenis atau pesaing
| Perusahaan | EPS | Perbedaan EPS | Negara |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| $0.56 | 411.78% |
IN
|
